The pharmaceutical company Aspen, from South Africa, intends to expand its operations in Brazil through acquisitions and partnerships. The drugmaker, which acquired Cellofarma in the Brazilian market in 2008, acts in generic, OTC and licensing.
See more: Valor Econômico| < Prev | Next > |
|---|
